Content by Tavaner Bushman
A recent study from Northwestern University has identified a possible new drug for people with Parkinson’s disease. Isradipine, a drug used to treat high blood pressure, has the potential to slow the aging of dopamine cells, whose death in the brain leads to the devastating disease.
Dopamine is a vital chemical messenger in the brain that affects the control of movement. When large numbers of dopamine-releasing neurons die, movement becomes difficult.